SipNose develops innovative Nasal delivery device focusing on Nose to Brain medical applications.
SipNose products are innovative, noninvasive, patent pending and are based on short time to market developing plan. The products are designed to be cost effective, high compliance and biocompatible.
On top of its innovative nasal delivery platform, SipNose is developing novel applications for unmet need clinical conditions, through its collaborations with pharmaceutical companies and academia leaders. Those innovative applications will perform a synergistic outcome subsequent to the compound-devise combination.
SipNose platform can bridge the gap between your CNS drug candidate (whether it is a small molecule, or a large protein) and its efficacy and safety measures.